* Achieves Midpoint For Enrollment In Phase 3 Trial Of AM111
in sudden deafness
The post BRIEF-Auris Medical provides update on key trial for sudden deafness appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Achieves Midpoint For Enrollment In Phase 3 Trial Of AM111
in sudden deafness
The post BRIEF-Auris Medical provides update on key trial for sudden deafness appeared first on NASDAQ.